Aromatase activity in receptor negative breast and endometrial cancer

Experimental Oncology

Volumn 25, Issue 3, 2003, Pages 228-230

  Berstein, L M ^a   Kovalevskij, A ^a   Larionov, A ^a   Tsyrlina, E ^a   Vasilyev, D ^a   Zimarina, T ^a   Thijssen, J H H ^b  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aromatase; Breast cancer; Endometrial cancer; Estrogen receptors; Progesterone receptors

Indexed keywords

ANDROSTENEDIONE; AROMATASE; ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; HORMONE RECEPTOR;

AROMATIZATION; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; POSTMENOPAUSE; TISSUE SPECIFICITY; MAJOR CLINICAL STUDY;

EID: 0142023016     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Habel LA, Stanford JL. Hormone receptors and breast cancer. Epidemiol Rev 1993; 15: 209-19.
2. Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W. Hormonal interactions in endometrial cancer. Endocrine-Related Cancer 2000; 7: 227-42.
3. Yasui Y, Potter JD. The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control 1999; 10: 431-7.
4. Saegusa M, Okayasu I. Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium. Jpn J Cancer Res 2000; 91: 510-8.
5. Zhu K, Bernard LJ, Levine RS, Williams SM. Estrogen receptor status of breast cancer: a marker of different stages of tumor or different entities of the disease? Med Hypotheses 1997; 49: 69-75.
6. Scawn R, Shousha S. Morphologic spectrum of estrogen receptor-negative breast carcinoma. Arch Pathol Lab Med 2002; 126: 325-30.
7. Fazzari A, Catalano MG, Comba A, Becchis M, Raineri M, Frairia R, Fortunati N. The control of estrogen and progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone binding globulin. Mol Cell Endocrinol 2001; 172: 31-6.
8. Colditz GA. Relationship between estrogen levels, receptors, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 1998; 90: 814-23.
9. Silva MC, Rowlands MG, Dowsett M, Gusterson B, McKinna JA, Fryatt I, Coombes RC. Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res 1989; 49: 2588-91.
10. Miller WR, Mullen P. Factors influencing aromatase activity in the breast. J Steroid Mol Biochem Mol Biol 1993; 44: 597-604.
11. Bolufer P, Ricart E, Iluch A. Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and EGF receptors and to tumor-node metastasis staging. J Clin Oncol 1992; 10: 438-46.
12. Abul-Hajj YH, Iverson R, Kiang DT. Aromatization of androgens by human breast cancer. Steroids 1979; 33: 205-22.
13. Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE, Chen S. Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation. Am J Pathol 1992; 140: 337-43.
14. Watanabe K, Sasano H, Harada N, Ozaki M, Niikura H, Sato S, Yajima A. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Am J Pathol 1995; 146: 491-500.
15. Tilson-Mallett N, Santner SJ, Feil PD, Santen RJ. Biological significance of aromatase activity in human breast tumors. J Clin Endocrinol Metabol 1983; 57: 1125-8.
16. Saez S, Martin PM, Chouvet CD. Oestradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels. Cancer Res 1978; 38: 3468-73.
17. Tsyrlina EV, Semiglazov VF, Moiseenko VM, Boronoeva TP. Study of the role of steroid receptors in human breast cancer. Neoplasma 1985; 32: 463-7.
18. Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR, Folsom AR. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 1995; 4: 319-26.
19. Berstein LM, Tsyrlina EV, Bychkova N, Kalinina N, Gamajunova V, Vasilyev D, Kovalenko I. Switching (over-targeting) of estrogen effects and its potential role in hormonal carcinogenesis. Neoplasma 2002; 49: 21-5.